American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
80 hedge funds and large institutions have $501M invested in American Renal Associates Holdings, Inc in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 5 closing their positions.
380% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
31% more funds holding
Funds holding: 61 → 80 (+19)
14% more capital invested
Capital invested by funds: $439M → $501M (+$62.2M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less call options, than puts
Call options by funds: $298K | Put options by funds: $306K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$6.8M |
| 2 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
+$5.07M |
| 3 |
Millennium Management
New York
|
+$2.66M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.63M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.2M |
| 2 |
Goldman Sachs
New York
|
-$9.11M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$1.07M |
| 4 |
AP
AHL Partners
London,
United Kingdom
|
-$507K |
| 5 |
Morgan Stanley
New York
|
-$271K |
ARA Hedge Fund Activity: Q4 2017 in Review
80 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q4 2017, worth a combined $501M — up 14% from $439M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ARA positions and 5 closed out — a net gain of 19 holders — while 28 added to existing stakes and 16 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $6.8M. The largest seller was Fidelity Investments, cutting an estimated $26.2M.
- 80 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q4 2017, up from 61 in Q3 2017.
- Funds reported $501M of American Renal Associates Holdings, Inc stock for Q4 2017, up 14% quarter-over-quarter.
- 24 funds opened new American Renal Associates Holdings, Inc positions in Q4 2017 and 5 closed out, a net change of +19 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q4 2017 was JP Morgan Chase, an estimated $6.8M added.
- The largest American Renal Associates Holdings, Inc seller in Q4 2017 was Fidelity Investments, an estimated $26.2M sold.
Based on aggregated 13F filings for Q4 2017.